Practical strategies for turning tutorials into active, inclusive learning spaces, from designing hands-on activities and valuing student contributions to building rapport and providing effective ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

The following members of the WKUHS team attended the Allscripts Client Experience (ACE) 2010 in Las Vegas during the first week of August: Dr Patricia Blewett, Donna Brosche, Mitzi Allen, Keith ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

“Today we’re announcing a new set of tutorials for students taking their first steps into coding with Swift and SwiftUI! You don’t need prior coding experience to use these tutorials, so they’re a ...

20-year-old Katie loves tutorial porn. The university student, who is using her first name only for privacy reasons, tells Mashable that it helped her to understand sex during a time where it ...

QuantHealth, an Israeli AI-enabled clinical trial-design startup, announced that David Dornstreich is joining the company as its general manager and chief commercial officer of U.S. operations, which ...

Allscripts is changing its corporate name to Veradigm, to reflect the health IT company’s focus on growth across each of its market segments, including payers, life sciences and providers, according ...

We spoke to exercise experts to find the ideal regimen. Credit...Joyce Lee for The New York Times Supported by By Ashley Abramson Q: How much cardiovascular exercise versus strength training should I ...

After shedding its hospital business segment earlier this year, health IT company Allscripts is doubling down on its strategy to grow its payers and life sciences businesses. Allscripts sold its ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.